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Immunologic Response of Infants to Combined 
Inactivated Measles-Poliomyelitis Vaccine** 
By 
Gordon C. Brown* 
With 2 Figures 
In  previous studies of inactivated poliomyelitis vaccine given to young 
infants, whether alone or in combination with other antigens such as 
diphtheria, tetanus and pertussis, the suppressive effect of maternal  
antibodies on active immunization has been repeatedly described. In- 
activated measles vaccine, however, has been studied primarily in pre- 
school or school children and very little information is available concerning 
the serologic response of young infants to it alone or combined with other 
antigens. The purpose of this s tudy was to determine the serologic 
response of 3 and 5 months old infants to a combined inactivated 
measles-poliomyelitis vaccine. 
Experimental 
The vaccine employed was an experimental preparation furnished 
by  the Pfizer Laboratories. The pr imary series consisted of three doses 
of 0.5 ml each injected intramuscularly at  intervals of two months. The 
selection of this schedule was chosen on the basis of previous studies by  
the author which showed it to be superior to a one month interval between 
injections during the pr imary series. The s tudy was carried out in the 
Well Baby Clinics of two hospitals in Ann Arbor. Forty-two infants 
received their vaccine at  the ages of 3, 5, and 7 months, and 23 infants 
were injected at 5, 7, and 9 months of age. Fifty-two of these 65 children 
were given a booster injection at  the age of 18 months, 11 and 9 months 
after the pr imary series respectively, depending upon the schedule. At 
this time, 9 children received an injection of live at tenuated measles 
vaccine and of killed poliomyelitis vaccine rather than the original corn- 
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bined preparation. Blood specimens were taken before and one month after 
the primary series, and before and two weeks after booster. In  addition, a 
small number of children were bled again 6 months following booster. 
Neutralizing antibodies for both viruses were determined in tissue culture 
tests* and, in addition, fluorescent antibody determinations were made 
using the indirect method. 
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Reactions 
Forty-seven of the infants in one clinic were followed for reactions to 
the vaccine by having the mothers report on specific reactions. Twenty 
infants showed fussiness, 16 had slight fever, or warmness, 4 lacked 
appetite and 6 showed slight or moderate local reactions at the si~e of 
injection. Many of the reactions followed the second dose of vaccine. 
The 9 infants who received live, attenuated vaccine for their booster 
were examined by a physician daily from the 5th through the 10th day 
following injection. These results are discussed later. 
* Neutralization tests for measles virus were performed in the laboratories 
of Chgs. Pfizer and Co. in Terre HouSe. Indiana. 
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Results 
The neutralizing antibody titers for poliomyelitis before and after both 
primary and booster immunization are shown in Fig. 1. I t  can be seen that  
many infants retained maternal antibodies at the third month of life and 
most of these failed to respond to primary vaccination with increased 
antibody titers. This confirms previous observations of the suppressive 
effect of passive antibodies on active immunization. In contrast, very few 
infants had maternal antibodies in high titer at 5 months of life illustrating 
the importance of the two additional months in allowing further passive 
antibody decay. Most infants with maternal antibodies in low or in non- 
detectable titer responded with antibody production although the type I I I  
antigen appeared to be the weakest of the 3 types. No apparent difference 
existed in the response of 
infants in the two age groups 
if uncomplicated by the pres- 
ence of maternal antibodies. 
The serologic response to 
booster inoculation was un- 
usually good when compared 
with previous studies which 
showed that  suppression of 
primary immunization fie- 
Table 1. P r i m a r y  r e sponse  of i n f a n t s  
to m e a s l e s - p o l i o m y e l i t i s  vacc ine  
Pre-primary Increase 
Age (month) Titer Nb. ,antibody titor 
<6 12 
6 or > 30 
<6 14 





quently resulted in unsatisfactory response to booster injections. In 
the present study only two infants were left without detectable anti- 
bodies following this stimulus. Furthermore, most of the titers attained 
following booster were quite high suggesting excellent protection 
against the disease. 
Thir ty of the 42 infants (71%) receiving their first injection at the age 
of 3 months had maternal antibodies for measles virus in titers of 1:6 
or greater. (Table 1.) Only 3 of these responded to the primary series with 
increased titers. In contrast 10 of the 12 infants with titers of less than 1 : 6 
responded. Only 9 of 23 infants (39%) injected first at the age of 5 months 
still had passive antibodies of 1 : 6 or greater and none of these responded. 
In contrast, all 14 with lower titers showed an increase. Thus, 60% of all 
the infants receiving vaccine at the age of 5 months responded immune- 
logically in contrast to only 28% of the total number started two months 
earlier. The significance of passive antibody suppression of primary response 
is illustrated by the fact that  two of these non-responding children deVe- 
loped clinical measles, 6 weeks and 5 months respectively, following the 
third injection of the primary series. 
Fig. 2 shows the neutralizing antibody titers for measles virus before 
and after primary and secondary immunization. Twenty-four of the 
23* 
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52 children bled at  the t ime of booster showed retention of antibodies, 
some in high Citer, 9 and 11 months after the pr imary series. This number  
might well have been considerably higher but  for the fact tha t  16 of the 
28 (57%) without antibodies at  this t ime were non-responders to pr imary 
series by  virtue of maternal  antibody suppression and did not have 
antibodies to retain. 
The response to booster injection must  be considered as highly satis- 
factory since only 2 children failed to show increased antibodies. Both 
of these, incidently, were non-responders to the pr imary series. In  general 
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Fig, 2. Measles neutral izing an t ibody  ti ters in infants  following combined inac t iva ted  
measles-poliomyelitis vaccine. 
the titers of antibody in post.booster sera were found to be high. No appar- 
ent difference in Citers was detected between those children who had 
received their first injection at  the age of 3 months or at 5 months. 
The 9 children who were given live, at tenuated virus vaccine for their 
boosters responded with Citers very similar to those found in children 
receiving killed vaccine. Table 2 presents the individual ant ibody Citers 
detected in these individuals together with the reactions seen. In  4 
of the 9, an elevated temperature was recorded, one had a moderate  
local reaction at the site of inoculation, another, a runny nose, and still 
another showed a transient rash and otitis media. Five were perfectly 
normal throughout the period of observation. On the basis of serologic 
and clinical response to booster it seems unlikely tha t  either of the 2 
children thought by  their private physicians to have had measles 
following pr imary series were in fact accurately diagnosed. 
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An interesting and potentially useful corollary to Shis study was the 
examination of all sera by the indirect method of fluorescent microscopy. 
Most specimens examined for poliomyelitis antibodies showed consider- 
able evidence of heterologous reactions between the three types suggesting 
strongly that  this technique is disease, rather than type, specific. On 
the other hand, very close agreement was observed between the measles 
neutralizing and fluorescent antibody titers demonstrating that  this 
procedure can be employed equally well for diagnosis and for research. 
Table 2. Sero logic  and  c l in i ca l  h i s t o r y  of i n f a n t s  r ece iv ing  l ive  
a t t e n u a t e d  meas les  v a c c i n e  b o o s t e r  f o l l o w i n g  ki l led  vacc ine  
p r i m a r y  ser ies  
F , L .  
K.E.  
D . W .  
T.B.  
S.H. 














* Clinical measles 
<4  <4  
6 9 
<4 *56 




<4  <4  
12 *<4 










Moderate fever 5**, 6, 7, 8 
Slight fever 6, 7, 8; 2 A- local 8, 9, 10 
Slight fever 5; runny nose 5, 6 






** Numbers indicate day. 
S u m m a r y  
The serologic response of young infants to combined, inactivated 
measles-poliomyelitis vaccine is described. Maternal antibodies to both 
diseases were present in many children at the age of 3 months and in 
some at the age of 5 months and when present, suppressed the primary 
response to vaccine. Booster injection of vaccine at the age of 18 months 
was successful in stimulating increased antibody titers in 96% of all the 
children. Booster doses of live attenuated measles virus instead of 
killed vaccine stimulated the production of comparable titers of anti- 
body. 
